VANCOUVER, British Columbia, March 16, 2022 (GLOBE NEWSWIRE) — Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) (“Pure Extracts” or the “Company”), a herbal extraction company focused on cannabis, hemp, functional mushrooms and the psychedelic, is delighted to announce that it has successfully exported its first batch of cannabis oil extracts to a German pharmaceutical company under an export permit from Health Canada.
Pure Extracts has purchased Canadian grown, EU-GMP certified dry cannabis flower and extracted it into 65% Pure THC (FSO) Full Spectrum Oil and 85% Pure THC Distillate. These extracts will then be processed in Germany into an ultra-pure form of THC for medicinal purposes.
This initial sale will pave the way for longer-term supply agreements to Germany, Europe’s most important market, and the Company plans to continue to seek export opportunities for its products in other European countries where they can be legally sold.
Pure Extracts CEO Ben Nikolaevsky said, “It is gratifying that our concentrates are selected by a German pharmaceutical company for use in their medical products. We are excited about all of the European market opportunities for our extracts.
ON BEHALF OF COUNCIL
CEO and Director
On Pure extracts (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ)
Pure Extracts Technology Corp. features a brand new, state-of-the-art processing facility located just 20 minutes north of the famous town of Whistler, BC. The bespoke facility was built to European Union GMP standards aimed at exporting products and formulations, including those currently restricted in Canada, to European jurisdictions where they are legally available. Pure Extracts obtained its standard processing license from Health Canada under the Cannabis Act on September 25, 2020 and its sale amendment on July 19, 2021. The company’s shares began trading on the Canadian Securities Exchange (CSE) on November 5, 2020.
Learn more about https://pureextractscorp.com/
Investor Relations Pure Extracts
Tel: +1 604 493 2052
This press release contains forward-looking statements relating to the future operations of Pure Extracts, and other statements are not historical facts. Forward-looking statements are often identified by words such as “will”, “may”, “should”, “anticipate”, “expect” and similar expressions. All statements other than statements of historical facts, included in this release, including, without limitation, statements regarding Pure Extracts’ future plans and objectives, are forward-looking statements and involve risks and uncertainties. A number of factors could cause actual events, performance or results to differ materially from what is projected in the forward-looking statements. Although we believe that the assumptions underlying these statements are reasonable, they may prove to be incorrect and we cannot guarantee that actual results will be consistent with these forward-looking statements. Given these risks, uncertainties and assumptions, investors should not place undue reliance on these forward-looking statements. Whether actual results, performance or achievements will be consistent with the Company’s expectations and projections is subject to a number of known and unknown risks, uncertainties, assumptions and other factors, including including those listed under “Risk Factors” in the Company’s Annual Information Form. The Company does not undertake to update any forward-looking information, except if and to the extent required by applicable securities laws.
This press release contains information about potential sales revenues from supply agreements, which may be considered financial outlook disclosure under applicable securities laws. This information is subject to the same assumptions, risk factors, limitations and qualifications as set out in the paragraph above. Specifically, the estimated sales revenues that may arise from supply contracts have been calculated based on current wholesale prices and assume, among other things, that the Company will be able to find buyers for its products. The financial outlook contained in this press release has been prepared by management as of the date of this press release and has been provided for the purpose of providing readers with an understanding of the potential revenues that may arise from any agreements recently entered into by the Company and do not constitute an estimate of profitability or any other measure of financial performance. Readers are cautioned that the financial outlook contained in this document should not be used for any purpose other than that for which it is disclosed herein.
The CSE has neither approved nor disapproved of the content of this press release.